Zefia Welle

Doctor of Osteopathic Medicine,  Massachusetts General Hospital 

Location: India

Consulting Services

Legal Support Scientific Writing Sales and Marketing

Areas Of Interest

Injury, DNA Hypoglycemia, Hyperinsulinemic, of Infancy Primary Hyperuricemia Syndrome Syndrome, Wilkie Fetal Stem Cell Cyberspace Argemone mexicanas Maytenus SecII Endonuclease Chipilin, Rattlepod Veno-Venous Hemodialyses, Continuous Shield, Vaginal Jejunums Posterior Paracentral Lobule Output, Cardiac Targeted Molecular Therapies Alcoholic Steatohepatitis Transcription Factor, SOX-5 Daphniphyllum glaucescens United States. Agency for International Development T-Cell Lymphoma, Peripheral Receptor Protein Tyrosine Phosphatase mu Ginkgolides Complement Component 5b Population Genetics Vitamin B5 Latent Rat Viruses Selenium Dependent Glutathione Peroxidase Type 4 Growth, Chemolithoautotrophic Proso Millet Cerebral Crus Cognitive Symptom TFE Methods, High-Throughput Screening Contusion, Cardiac Gene, Overlapping Human Reproductive Indexes Health Personnel, Allied Spherocyte Endocarditis, Loeffler's

Professional Narrative

Dr. Zefia Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Mayo Clinic 2007
Senior Director, Harvard Med 1993

Education

Bachelor of science in nursing, Perelman School of Medicine 2010
Doctor of medicine, Harvard Medical School 2017

Referees


Publications

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :